title: Accelerating failure rate of the ASR total hip replacement.
abstract: There is widespread concern regarding the incidence of adverse soft-tissue reactions after metal-on-metal (MoM) hip replacement. Recent National Joint Registry data have shown clear differences in the rates of failure of different designs of hip resurfacing. Our aim was to update the failure rates related to metal debris for the Articular Surface Replacement (ASR). A total of 505 of these were implanted. Kaplan-Meier analysis showed a failure rate of 25% at six years for the ASR resurfacing and of 48.8% for the ASR total hip replacement (THR). Of 257 patients with a minimum follow-up of two years, 67 (26.1%) had a serum cobalt concentration which was greater than 7 μg/l. Co-ordinate measuring machine analysis of revised components showed that all patients suffering adverse tissue reactions in the resurfacing group had abnormal wear of the bearing surfaces. Six THR patients had relatively low rates of articular wear, but were found to have considerable damage at the trunion-taper interface. Our results suggest that wear at the modular junction is an important factor in the development of adverse tissue reactions after implantation of a large-diameter MoM THR.
authors.affiliation: Northern Deanery, Goldcrest Way, Newcastle upon Tyne NE15 8NY, UK. djlangton22@doctors.org.uk
authors.forename: D J
authors.initials: DJ
authors.lastname: Langton
authors.forename: S S
authors.initials: SS
authors.lastname: Jameson
authors.forename: T J
authors.initials: TJ
authors.lastname: Joyce
authors.forename: J N
authors.initials: JN
authors.lastname: Gandhi
authors.forename: R
authors.initials: R
authors.lastname: Sidaginamale
authors.forename: P
authors.initials: P
authors.lastname: Mereddy
authors.forename: J
authors.initials: J
authors.lastname: Lord
authors.forename: A V F
authors.initials: AV
authors.lastname: Nargol
mesh_terms: D019644:Arthroplasty, Replacement, Hip / Q000009:adverse effects / Q000379:methods; D002857:Chromium / Q000097:blood; D003035:Cobalt / Q000097:blood; D004812:Epidemiologic Methods; D019544:Equipment Failure Analysis / Q000379:methods; D005260:Female; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D008297:Male; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012086:Reoperation
chemical_list: D002857:Chromium; D003035:Cobalt